236 related articles for article (PubMed ID: 17045011)
1. [Epirubicin in the treatment of malignant obstructive jaundice].
Chen Y; Yan ZP; Wang JH; Wang XL; Cheng JM; Gong GQ; Liu QX; Qian S; Liu R; Luo JJ
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):397-9. PubMed ID: 17045011
[TBL] [Abstract][Full Text] [Related]
2. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
4. Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
Tzeng WS; Wu RH; Chang SC; Chou CK; Lin CY; Chen JJ; Yang SC; Lin CH
J Vasc Interv Radiol; 2008 Mar; 19(3):342-50. PubMed ID: 18295692
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
[TBL] [Abstract][Full Text] [Related]
6. Interventional therapy of malignant obstructive jaundice.
Feng GH; Cai Y; Jia Z; Yang DQ; Chen H; Jin HC; Yu QH; Zhu W; Wang CX
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):300-2. PubMed ID: 14599989
[TBL] [Abstract][Full Text] [Related]
7. Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.
Pietrosi G; Miraglia R; Luca A; Vizzini GB; Fili' D; Riccardo V; D'Antoni A; Petridis I; Maruzzelli L; Biondo D; Gridelli B
J Vasc Interv Radiol; 2009 Jul; 20(7):896-902. PubMed ID: 19497762
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the therapeutic effects of PTBD and PTBS in treatment of malignant obstructive jaundice].
Bai AG; Zheng CS; Zhou GF; Liang HM; Feng GS
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):456-8. PubMed ID: 20819490
[TBL] [Abstract][Full Text] [Related]
9. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
[TBL] [Abstract][Full Text] [Related]
10. [Long-term results of chemoembolization of primary liver cancer with epirubicin-lipiodol].
Pirschel J; Lauchart W
Helv Chir Acta; 1993 Mar; 59(4):631-6. PubMed ID: 8386147
[TBL] [Abstract][Full Text] [Related]
11. [Transhepatic arterial chemoembolization by epirubicin mixed with microspheres for hepatocellular carcinoma].
Luo JJ; Yan ZP; Wang JH; Liu QX; Chen Y
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):619-22. PubMed ID: 18210885
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma.
Hong HP; Kim SK; Seo TS
J Vasc Interv Radiol; 2008 May; 19(5):748-54. PubMed ID: 18440465
[TBL] [Abstract][Full Text] [Related]
15. Intraarterial chemoembolisation with lipiodol and epirubicin in hepatocellular cancer--improved survival in some patients?
Karlson BM; Löfberg AM; Lörelius LE; Jacobson G; Haglund U
Ann Chir Gynaecol; 1999; 88(4):264-8. PubMed ID: 10661821
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
[TBL] [Abstract][Full Text] [Related]
17. Development of a safety index of transarterial chemoembolization for hepatocellular carcinoma to prevent acute liver damage.
Hwang JI; Chow WK; Hung SW; Li TC; Cheng YP; Ho YJ; Lin CC
Anticancer Res; 2005; 25(3c):2551-4. PubMed ID: 16080491
[TBL] [Abstract][Full Text] [Related]
18. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
[TBL] [Abstract][Full Text] [Related]
19. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors.
Lee JW; Han JK; Kim TK; Choi BI; Park SH; Ko YH; Yoon CJ; Yeon KM
Cardiovasc Intervent Radiol; 2002; 25(3):176-9. PubMed ID: 12058212
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of advanced Wilms' tumor].
Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
